spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Johnson & Johnson, 

 HSMN NewsFeed - 6 Mar 2026
U.S. FDA Approves TECVAYLI(R) in Combination with DARZALEX FASPRO(R) for Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology Drug Delivery FDA
 HSMN NewsFeed - 22 Jan 2026
Resolve M Therapeutics Exits From Stealth
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2025
Johnson & Johnson Launches VOLT(TM) Wrist and Proximal Humerus Plating Systems in the U.S.
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 2 Apr 2025
Append Medical Appoints Shlomi Nachman as Chairman of the Board
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 15 Jan 2025
New Drug Application Initiated with U.S. FDA for TAR-200, the First and Only Intravesical Drug Releasing System for Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 8 Jan 2025
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Devices Cardiology FDA
 HSMN NewsFeed - 10 Oct 2024
Johnson & Johnson MedTech Launches VOLT(TM) Plating System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 3 Sep 2024
Forward Therapeutics Welcomes Ulrich Thienel, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2024
RYBREVANT(R) (amivantamab-vmjw) Plus LAZCLUZE(TM) (lazertinib) Approved in the U.S. as a First-line Chemotherapy-free Treatment for Patients with EGFR-mutated Advanced Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2024
CereVasc Announces Appointments of New Directors
Devices Neurosurgery Personnel
 HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jun 2024
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS(TM) Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures
Devices Orthopaedic FDA
 HSMN NewsFeed - 7 Nov 2023
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
Devices Surgery FDA
 HSMN NewsFeed - 27 Jun 2023
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2022
Janssen Submits Biologics License Application to U.S. FDA for Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Oct 2022
DePuy Synthes Receives FDA Clearance for TELIGEN(TM) System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 6 Jun 2022
Medcura Appoints Surgical Medical Device Leader Jim Buck as New CEO
Devices Surgery Personnel
 HSMN NewsFeed - 6 Jun 2022
Ethicon Launches Next Generation Echelon(TM) 3000 Stapler Designed for Exceptional Access and Control
Devices Surgery Product Launch
 HSMN NewsFeed - 17 May 2022
Remix Therapeutics Closes $70 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Dec 2021
Johnson & Johnson Appoints Senior Leaders to Executive Committee
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2021
BD Names Dr. Joseph M. Smith as Chief Scientific Officer
Devices Personnel
 HSMN NewsFeed - 24 Nov 2021
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
Devices Diagnostics Personnel
 HSMN NewsFeed - 12 Nov 2021
Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business
Devices Biopharmaceuticals
 HSMN NewsFeed - 12 Oct 2021
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2021
DePuy Synthes Introduces the INHANCE(TM) Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 11 Aug 2021
Ethicon's Echelon Circular Powered Stapler Associated With Major Reduction In Serious Complications Following Colorectal Surgery
Devices Surgery
 HSMN NewsFeed - 12 Jul 2021
Janssen Announces U.S. FDA Approval of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jun 2021
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
Devices Surgery Product Launch
 HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Jun 2021
Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Mar 2021
Johnson & Johnson Vision Receives Approval of World's First and Only Drug-Releasing Combination Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE(R) Theravision(TM) with Ketotifen
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 17 Mar 2021
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2021
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Feb 2021
Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2021
Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2021
OncoSec Strengthens Management Team With Two New Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Oct 2020
Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2020
KAHR Announces Two Key Appointments to Strengthen Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Sep 2020
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2020
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
Biopharmaceuticals
 HSMN NewsFeed - 19 Aug 2020
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2020
FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Aug 2020
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 30 Jul 2020
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
Biopharmaceuticals
 HSMN NewsFeed - 17 Jul 2020
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement in Patients Living with X-Linked Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 14 Jul 2020
TREMFYA(R) (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jul 2020
inHEART Raises $4.2 Million to Improve Treatments for Cardiac Arrhythmias With Medical Imaging, Artificial Intelligence and Numerical Simulations
Devices Cardiology Venture Capital
 HSMN NewsFeed - 26 Jun 2020
Janssen Announces Discontinuation of Phase 3 LOTUS Study Evaluating Ustekinumab in Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2020
Akero Therapeutics Appoints Tom Heyman to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2020
Dymicron(TM) Expands Leadership Team, Adds Significant Experience of Industry Veterans Ted Bird and Eric Lange
Devices Orthopaedic Personnel
 HSMN NewsFeed - 9 Apr 2020
BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2020
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Biopharmaceuticals
 HSMN NewsFeed - 13 Jan 2020
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular Degeneration (AMD) and Diabetic Macular Edema
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Dec 2019
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 8 Nov 2019
Janssen Announces Submission of Supplemental New Drug Application to U.S. FDA Seeking Approval of IMBRUVICA(R) (ibrutinib) in Combination with Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Oct 2019
NeuroRx Secures HK$ 750 Million Capital Commitment From The Gem Group for Development of NRX-101
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Oct 2019
Johnson & Johnson Consumer Inc. To Voluntarily Recall A Single Lot Of Johnson's Baby Powder In The United States
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 4 Oct 2019
Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 30 Sep 2019
Johnson & Johnson Vision Care, Inc. Introduces ACUVUE(TM) RevitaLens Multi-Purpose Disinfecting Solution, the Brand's First Contact Lens Solution
Biopharmaceuticals Devices Ophthalmology Product Launch
 HSMN NewsFeed - 9 Jul 2019
BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2019
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jun 2019
Janssen reports top-line Phase 3 results for TREMFYA(R) (guselkumab) in adults with active psoriatic arthritis
Biopharmaceuticals
 HSMN NewsFeed - 25 Apr 2019
DURECT Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Feb 2019
Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2019
U.S. FDA Approves DARZALEX(R) (daratumumab) Split-Dosing Regimen
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Jan 2019
U.S. FDA Approves IMBRUVICA(R) (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Jan 2019
Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention
Devices Cardiology Monitoring
 HSMN NewsFeed - 3 Dec 2018
Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 14 Nov 2018
Abyrx(R) Appoints Gary D. Cohn as Director
Devices Surgery Personnel
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 6 Sep 2018
Johnson & Johnson Vision Launches Next Generation of Personalized LASIK Treatment, iDESIGN Refractive Studio Now Available
Devices Ophthalmology FDA Product Launch
 HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 Aug 2018
Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX(R) (daratumumab) Split Dosing Regimen
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 22 May 2018
New GLOBAL UNITE Reverse Fracture Shoulder Implant from DePuy Synthes Addresses Unmet Needs in Complex Shoulder Fractures
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
Devices Interventional Radiology Neurology FDA
 HSMN NewsFeed - 30 Apr 2018
Actelion Submits Supplemental New Drug Application to US FDA Seeking Approval of OPSUMIT(R) (macitentan) for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2018
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
Devices Monitoring Endocrinology Acquisitions
 HSMN NewsFeed - 15 Mar 2018
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer
Biopharmaceuticals Oncology Urology FDA
 HSMN NewsFeed - 20 Feb 2018
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics
Devices Mergers & Acquisitions
 HSMN NewsFeed - 8 Feb 2018
ZYTIGA(R) (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Jan 2018
Johnson & Johnson Vision Expands Parameter Offering for 1-DAY ACUVUE(R) MOIST Brand Contact Lenses for ASTIGMATISM
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 19 Jan 2018
Gathering Together World-Renowned Medical Device Manufacturing Suppliers, Medtec China Helps to Propel the Medical Device Localization Process
Devices Regulatory
 HSMN NewsFeed - 11 Jan 2018
First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Jan 2018
New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
Devices Surgery Product Launch
 HSMN NewsFeed - 12 Dec 2017
DARZALEX(R) (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces TearScience LipiScan(R) and LipiFlow(R) Now Available in More Than 800 Eye Care Practices to Image Meibomian Glands and Treat Meibomian Gland Dysfunction
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces Series of Product Milestones and Launches Across Portfolio at American Academy of Ophthalmology 2017 Meeting
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Medical Devices Companies Unveils State of the Art "Engineering Studio" at Texas Medical Center to Accelerate Medical Devices Development
Devices
 HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Oct 2017
New DePuy Synthes Spine Technologies Help Simplify Minimally Invasive Surgery by Enhancing Efficiency and Reducing Steps
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 19 Oct 2017
Johnson & Johnson Medical GmbH to Acquire Surgical Process Institute
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 12 Oct 2017
New System Designed to Enhance Implant Fixation for Hip Fracture Patients with Poor Bone Quality Launches in the U.S.
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 11 Oct 2017
Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Oct 2017
Animas Corporation to Close Operations and Exit Insulin Pump Market
Devices Endocrinology
 HSMN NewsFeed - 15 Sep 2017
Janssen Receives CHMP Positive Opinion for Guselkumab Recommending Approval for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 7 Sep 2017
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2017
Johnson & Johnson Medical Devices Companies Signals Commitment to Stroke Treatment With the Announcement of New Neurovascular Business
Devices Neurology Interventional
 HSMN NewsFeed - 6 Sep 2017
Actelion Receives FDA Approval Of TRACLEER(R) (bosentan) For Use In Pediatric Patients With Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Aug 2017
Exclusive Agreement to Co-market Proprietary Software Platform to Aid in Total Hip Replacement Announced Between DePuy Synthes and JointPoint, Inc.
Devices Orthopaedic
 HSMN NewsFeed - 21 Aug 2017
Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
Devices Surgery Product Launch
 HSMN NewsFeed - 27 Jun 2017
DePuy Synthes Announces Acquisition of Sentio, LLC to Enable Innovation in Minimally Invasive Spine Surgery
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 16 Jun 2017
Johnson & Johnson Announces Completion of Acquisition of Actelion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Jun 2017
Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2017
Janssen Enters Into Worldwide Exclusive License and Collaboration Agreement With Protagonist Therapeutics, Inc. for Oral Interleukin-23 Receptor Antagonist Drug Candidate for the Treatment of Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 5 May 2017
New ECHELON FLEX(TM) GST System (45mm) Delivers Benefits of Precision Stapling Performance to Thoracic and Colorectal Procedures
Devices Surgery Product Launch
 HSMN NewsFeed - 18 Apr 2017
RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2017
Foresee Pharmaceuticals Announces Key Executive Appointments
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Apr 2017
Codman Neuro Announces Acquisition Of Neuravi Limited To Accelerate Innovation In Acute Ischemic Stroke Therapy
Devices Neurology Interventional Mergers & Acquisitions
 HSMN NewsFeed - 13 Mar 2017
OrthoGrid Systems, Inc. Announces Mark J. Carrico as Director of Marketing
Devices Orthopaedic Personnel
 HSMN NewsFeed - 8 Mar 2017
AzurRx Announces Addition of Charles J Casamento to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2017
Ethicon Launches ENSEAL(R) X1 Large Jaw Tissue Sealer, Establishing Next Generation Of Advanced Bipolar Devices
Devices Surgery Product Launch
 HSMN NewsFeed - 1 Mar 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
Devices Oncology Personnel
 HSMN NewsFeed - 13 Feb 2017
DePuy Synthes Launches ViviGen Formable(TM) Cellular Bone Matrix, Providing a New Cellular Allograft with Alternative Consistency for Spinal Fusion Surgery
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 31 Jan 2017
Bellicum Announces Appointment of Rick Fair as Chief Executive Officer in Preparation for Commercialization of BPX-501 and Next Phase of Growth
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jan 2017
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc.
Devices Orthopaedic Distribution
 HSMN NewsFeed - 9 Jan 2017
Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2017
Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
Devices Personnel
 HSMN NewsFeed - 16 Dec 2016
Janssen Submits Application Seeking FDA Approval of STELARA(R) (Ustekinumab) for the Treatment of Adolescents with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 14 Dec 2016
Health Canada approves STELARA(R) for the treatment of adults with moderately to severely active Crohn's disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 14 Dec 2016
Johnson & Johnson Announces it has Ended Discussions with Actelion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Dec 2016
Inogen Announces Management Transitions and Expanded Board of Directors
Devices Personnel
 HSMN NewsFeed - 22 Nov 2016
DARZALEX(R) (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Sep 2016
U.S. FDA Approves INVOKAMET(R) XR (Canagliflozin / Metformin Hydrochloride Extended-Release) for the Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 7 Sep 2016
Marinus Appoints Seth H.Z. Fischer to its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Jul 2016
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate Immuno-oncology Combination in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Apr 2016
Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 6 Apr 2016
Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 29 Mar 2016
Via Surgical Ltd. Announces the Appointment of John Gomes as its Chief Commercial Officer
Devices Surgery Personnel
 HSMN NewsFeed - 3 Mar 2016
Kris Peterson to Join Paratek Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2016
Lumira Capital Announces Expansion of Investment Team with Appointment of Three Venture Partners
Devices Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 Feb 2016
New OneTouch Verio Flex(TM) Blood Glucose Meter Takes the Guesswork Out of Blood Sugar Test Results
Devices Monitoring Endocrinology Product Launch
 HSMN NewsFeed - 28 Jan 2016
DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson
Devices Diagnostics Litigation
 HSMN NewsFeed - 19 Jan 2016
Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace
Devices Personnel
 HSMN NewsFeed - 11 Jan 2016
Bioventus Board of Managers Appoints Bill Hawkins Chairman
Devices Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 7 Jan 2016
Alector Announces Closing of Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 3 Nov 2015
TransEnterix, Inc. Appoints Steven Boudrez as Vice President of Sales, Europe
Devices Surgery Personnel
 HSMN NewsFeed - 3 Nov 2015
CureVac raises $110 Million in a private placement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Oct 2015
Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Oct 2015
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2015
Elixir Medical Corporation Expands Commercial Operations with Addition of Michele Perrino as President, Commercial and Manufacturing Operations
Devices Interventional Personnel
 HSMN NewsFeed - 14 Aug 2015
Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Aug 2015
Aratana Therapeutics Elects Wendy Yarno as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2015
Ophthotech Announces New Senior Leadership Appointments
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 16 Jul 2015
Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2015
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
Devices Wound Care Personnel
 HSMN NewsFeed - 30 Apr 2015
ConvaTec Appoints Paul Moraviec CEO Effective April 30, 2015
Devices Personnel
 HSMN NewsFeed - 19 Mar 2015
Janssen Acquires XO1 Limited
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Feb 2015
Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation
Devices Litigation
 HSMN NewsFeed - 20 Jan 2015
Akers Expands U.S. Sales Efforts With Key Leadership Additions
Diagnostics Personnel
 HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Biopharmaceuticlas Oncology Personnel
 HSMN NewsFeed - 19 Nov 2014
Cordis Corporation Leads With Strong Podium Presence At VEITH 2014 With First-Ever Presentation Of Three-Year INCRAFT(R) System Data
Devices Interventional
 HSMN NewsFeed - 22 Sep 2014
Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2014
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2014
Covidien Files Patent Infringement Lawsuit over Ethicon's Ultrasonic Surgical Devices
Devices Litigation
 HSMN NewsFeed - 6 Jun 2014
Immune Appoints Gad Berdugo to Board of Directors and Karin Hehenberger, M.D., Ph.D to Senior Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2014
Aduro Announces License Agreement with Johnson & Johnson Innovation for Novel Immunotherapies for Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 5 May 2014
SAGE Therapeutics Appoints Thomas D. Anderson as Chief Commercial Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2014
Johnson & Johnson Announces Acceptance Of Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2014
Portola Pharmaceuticals Appoints John H. Johnson to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2014
Arvinas Hires Jim Winkler as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2014
Miraculins Executes Term Sheet to Appoint Cachet Pharmaceutical as Exclusive Distributor of the Scout DS(R) Diabetes Test in China
Diagnostics Endocrinology Distribution
 HSMN NewsFeed - 28 Jan 2014
Two-Year Data from INNOVATION Trial on INCRAFT(R) AAA Stent Graft System Continues to Demonstrate Safety and Performance in Treatment of Abdominal Aortic Aneurysms
Devices Interventional
 HSMN NewsFeed - 24 Jan 2014
Court Rules in Favor of Covidien in Ethicon Patent Infringement Lawsuit
Devices Surgery Litigation
 HSMN NewsFeed - 22 Jan 2014
Janssen Announces New Group Targeting Unmet Global Health Needs
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2014
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2014
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2014
Seattle Genetics Appoints John A. Orwin to Board of Directors
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
Cempra, Inc. Names David Moore as Chief Commercial Officer to Manage Commercial Development and Launch of Solithromycin and Taksta(TM)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2014
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 2 Jan 2014
SpineGuard Names Pierre Guyot to Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 4 Nov 2013
EndoEvolution Announces the Appointment of Two Board Members
Devices Surgery Personnel
 HSMN NewsFeed - 1 Oct 2013
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 30 Sep 2013
Alkermes Expands Senior Management Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Aug 2013
ACADIA Pharmaceuticals Announces Appointment of Terrence Moore as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Jul 2013
KCI to Acquire Systagenix
Devices Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 12 Jul 2013
Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Vascular Closure Devices
Devices Group Purchasing
 HSMN NewsFeed - 17 Jun 2013
Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Jun 2013
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
Devices
 HSMN NewsFeed - 22 May 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2013
Cordis Acquires Flexible Stenting Solutions, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2012
Titan Pharmaceuticals Licenses Exclusive Probuphine(R) Commercialization Rights in U.S. and Canada to Braeburn Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 10 Dec 2012
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2012
Savient Announces the Election of Robert G. Savage to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2012
Sorbent Therapeutics Appoints Jason Levin Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Nov 2012
John A. Orwin Joins Array BioPharma Board Of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Nov 2012
Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific
Devices Interventional Personnel
 HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 4 Oct 2012
Ethicon Announces Launch of STRATAFIX(TM) Knotless Tissue Control Devices
Devices Surgery
 HSMN NewsFeed - 1 Oct 2012
James E. Burke, Former Chairman and CEO of Johnson & Johnson, Dies at 87
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2012
Circassia Appoints Stewart Sharpe as Vice President Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2012
FORMA Therapeutics Appoints Dr. Rob Sarisky to Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Aug 2012
ADVENTRX Announces Appointment Of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2012
OmniGuide Appoints Tracy Campbell Accardi as Chief Technology Officer
Devices Surgery Personnel
 HSMN NewsFeed - 15 Jun 2012
ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 11 Jun 2012
Veteran Medical Technology Executive and Industry Expert Peter Soderberg Invests in EarlySense and Joins the Company’s Board of Directors
Devices Monitoring Venture Capital Personnel
 HSMN NewsFeed - 22 May 2012
MagForce signs distribution agreement with leading Russian medical device distribution company DELRUS
Devices Oncology Distribution
 HSMN NewsFeed - 10 May 2012
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2012
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Devices Acquisitions
 HSMN NewsFeed - 25 Apr 2012
Coronado Biosciences Promotes Karin Hehenberger, M.D., Ph.D., to Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2012
Donald M. Casey Jr. Joins Cardinal Health as CEO of Medical Segment
Devices Personnel
 HSMN NewsFeed - 27 Mar 2012
VIVUS Announced Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2012
Paradigm Spine, LLC Announces Strategic Promotions and Hiring of Key Personnel to Ensure Long-Term Growth and Success
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 30 Jan 2012
ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jan 2012
Boston Scientific Announces Favorable Ruling in Patent Infringement Case
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 Jan 2012
Covidien CEO Elected Chairman of the Board
Devices Personnel
 HSMN NewsFeed - 6 Dec 2011
Amneal Announces Corporate Business Development Team
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 31 Oct 2011
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2011
Aegerion Pharmaceuticals Appoints Craig E. Fraser as President, U.S.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2011
Cardica Appoints Christopher Littel VP, Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 28 Sep 2011
Ethicon Endo-Surgery to Acquire SterilMed
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Sep 2011
Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan
Devices Interventional Personnel
 HSMN NewsFeed - 12 Sep 2011
SuperGen, Inc. Changes Name to Astex Pharmaceuticals, Inc., Announces New Stock Ticker Symbol and New Website
Biopharmaceuticals
 HSMN NewsFeed - 8 Sep 2011
FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 6 Sep 2011
Savient Announces the Election of William F. Owen, Jr., M.D. and David Y. Norton to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2011
Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2011
Celldex Expands Senior Management Team with Appointment of Dr. Ronald A. Pepin, Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2011
SonoSite Announces Two Senior Management Appointments Aimed at Driving Top-Line Execution and Margin Expansion
Devices Personnel
 HSMN NewsFeed - 27 Jun 2011
Arno Therapeutics Names Alexander Zukiwski, M.D., Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2011
Jules A. Müsing Joins iBio’s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2011
SurModics Comments on Johnson & Johnson Announcement
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2011
Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2011
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Jun 2011
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 16 May 2011
Cordis Launches Integrated Solutions for Transradial Care
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2011
Cordis Launching Two New Products at EuroPCR Congress
Devices Interventional Cardiology
 HSMN NewsFeed - 9 May 2011
Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Apr 2011
Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 15 Apr 2011
Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck
Biopharmaceuticals Distribution
 HSMN NewsFeed - 4 Apr 2011
PERCIVIA LLC Appoints Amit D. Munshi, President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2011
Cordis Demonstrates Commitment to Advancing Therapies for Below-the-Knee Vascular Disease
Devices Interventional
 HSMN NewsFeed - 21 Mar 2011
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 16 Mar 2011
Covidien Elects Jose E. Almeida President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 24 Feb 2011
Spectrum Pharmaceuticals Appoints Steven M. Fruchtman, MD, an Industry Veteran, as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2011
Labopharm Announces Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2011
Angelini Labopharm Confirms Appointment of Mary Anne Heino as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2011
Symmetry Medical Board of Directors Appoints Thomas J. Sullivan President and Chief Executive Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 7 Jan 2011
JPB Capital Partners and Ilex Consumer Products Group Acquire ST. JOSEPH'S(R) ASPIRIN Brand From Johnson & Johnson
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 Dec 2010
Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2010
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Diagnostic and Interventional Cardiology Products
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 15 Nov 2010
Christine A. Poon Elected to Regeneron Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2010
Rivaroxaban Significantly Reduces Risk of Stroke in Patients With Atrial Fibrillation With Comparable Safety vs. Warfarin in Pivotal Phase 3 Study
Biopharmaceuticals Cardiology Neurology
 HSMN NewsFeed - 1 Nov 2010
Hill-Rom Appoints Mark Guinan as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 11 Oct 2010
Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Sep 2010
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Sep 2010
Acclarent, Inc. Introduces Two New Innovations for Minimally-Invasive Sinus Surgery during AAO - Head and Neck Surgery Conference
Devices Surgery
 HSMN NewsFeed - 14 Sep 2010
AAIPharma Services Corp. Names Patrick Walsh Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2010
Protalix BioTherapeutics Names Tzvi Palash Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Aug 2010
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 26 Aug 2010
DePuy Orthopaedics Voluntarily Recalls ASR Hip System
Devices Orthopaedic Product Recall
 HSMN NewsFeed - 12 Jul 2010
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Devices Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 12 Jul 2010
Ethicon Endo-Surgery Completes Divestiture of Breast Care Business to Devicor Medical Products
Devices Surgery Acquisitions
 HSMN NewsFeed - 7 Jul 2010
Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant
Devices FDA
 HSMN NewsFeed - 22 Jun 2010
International Stem Cell Corporation Names Charles J. Casamento to Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 16 Jun 2010
HEALTHPOINT, Ltd. Announces New Vice President, Sales Brad Adams
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 3 Jun 2010
DFine Appoints Jim Mazzarella to the Position of Vice President of Sales
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 3 Jun 2010
Biodel Appoints Donald Casey, Jr. to Board of Directors
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 May 2010
CORDIS Launches ExoSeal(TM) Vascular Closure Device
Devices Interventional
 HSMN NewsFeed - 25 May 2010
NEVO Sirolimus-eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2010
AngioDynamics Appoints Lynda Wallace Senior Vice President of Business Development
Devices Personnel
 HSMN NewsFeed - 13 Apr 2010
FDA Approves New Drug Application for PANCREAZE(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Mar 2010
Ethicon Endo-Surgery Announces Receipt of Offer to Purchase Breast Care Business
Devices Acquisitions
 HSMN NewsFeed - 24 Mar 2010
Gardner Named President/CEO at EuroMed
Devices Wound Care Personnel
 HSMN NewsFeed - 11 Mar 2010
Cordis Unveils Next Generation CoCr Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Mar 2010
Bioness Appoints New President and CEO
Devices Neurology Personnel
 HSMN NewsFeed - 3 Mar 2010
AGA Medical Announces Promotion of Three Senior Executives
Devices Personnel
 HSMN NewsFeed - 8 Feb 2010
Aton Pharma Announces Michael H. Richardson to Head Orphan Drug Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2010
Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes
Devices Litigation Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2010
Boston Scientific Settles Longstanding Patent Disputes With J&J
Devices Litigation Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2010
Human Genome Sciences Names Scott Habig Vice President, Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jan 2010
Ethicon Completes Acquisition of Acclarent
Devices Mergers & Acquisitions
 HSMN NewsFeed - 20 Jan 2010
Court Finds J&J Patents Invalid
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 14 Jan 2010
STELARA(TM) (ustekinumab) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 30 Dec 2009
FDA Issues Complete Response Letter for Ceftobiprole
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Dec 2009
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2009
Ethicon Announces Definitive Agreement to Acquire Acclarent
Devices Mergers & Acquisitions
 HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Nov 2009
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2009
Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses
Devices Ophthalmology
 HSMN NewsFeed - 16 Oct 2009
Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
Devices Dermatology Licensing
 HSMN NewsFeed - 29 Sep 2009
SafeStitch Medical, Inc. Appoints Dr. Chao Chen to Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 28 Sep 2009
Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment
Biopharmaceuticals
 HSMN NewsFeed - 15 Sep 2009
Caris Diagnostics Appoints Thomas T. Spalding to Senior Vice President, Chief Marketing Officer
Diagnostics Personnel
 HSMN NewsFeed - 14 Sep 2009
Elan Cures Breach of Tysabri(R) Collaboration Agreement and Amends Terms of Transaction with Johnson & Johnson
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2009
Natus Medical to Acquire Alpine Biomed
Devices Monitoring Neurology Mergers & Acquisitions
 HSMN NewsFeed - 21 Jul 2009
AngioDynamics Appoints Shawn McCarthy Senior Vice President and General Manager of Its Peripheral Vascular Business Unit
Devices Personnel
 HSMN NewsFeed - 15 Jul 2009
Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jul 2009
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Jun 2009
DexCom Names Richard B. Doubleday Vice President of Sales
Devices Personnel
 HSMN NewsFeed - 21 May 2009
Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 11 May 2009
Bausch & Lomb Appoints Global Vision Care and North American Vision Care Presidents
Devices Ophthalmology Personnel
 HSMN NewsFeed - 9 Apr 2009
New Clinical Data at ACC09 Show the CYPHER Sirolimus-eluting Coronary Stent Outperformed TAXUS LIBERTE and ENDEAVOR Stents in Key Outcome Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Apr 2009
Cohera Medical Names William M. Cotter as Company's First Vice President of Manufacturing
Devices Wound Care Personnel
 HSMN NewsFeed - 2 Apr 2009
Jazz Pharmaceuticals, Inc. Announces Board of Directors and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2009
TYRX Announces the Appointment of George D. Landau as Vice President, Business Development
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 26 Mar 2009
MacroGenics Appoints New Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2009
Cordis Celebrates 50 Years of Transforming Cardiovascular Care
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Mar 2009
Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company
Devices Surgery Cardiology Personnel
 HSMN NewsFeed - 16 Mar 2009
Cordis Corporation Announces Head-to-Head Randomized Clinical Trial Comparing the NEVO Sirolimus-Eluting Coronary Stent to the XIENCE Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2009
GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery
Devices Surgery
 HSMN NewsFeed - 5 Mar 2009
CYPHER Sirolimus-eluting Coronary Stent Demonstrates Sustained Benefits Compared to Bare-Metal Stents in Six-Year Randomized Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Feb 2009
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Feb 2009
Basilea Pharmaceutica files claims against Johnson&Johnson over its handling of ceftobiprole (ZEFTERA(TM)/Zevtera(TM)) clinical studies
Biopharmaceuticals Litigation
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Feb 2009
PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 10 Feb 2009
FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2009
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jan 2009
Johnson & Johnson Completes Acquisition of Mentor Corporation
Devices Mergers & Acquisitions
 HSMN NewsFeed - 23 Jan 2009
Johnson & Johnson Completes Tender Offer for Mentor Corporation
Devices Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2009
Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care
Devices Ophthalmology Personnel
 HSMN NewsFeed - 13 Jan 2009
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2009
Synergetics USA, Inc. Announces Three Month Extension of Current Agreements with Codman & Shurtleff, Inc. as Longer Term Agreement Negotiations Continue
Devices Neurosurgery Licensing
 HSMN NewsFeed - 27 Dec 2008
Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2008
ETHICON Launches the Latest Innovation in Hernia Repair Platform; PROCEED(TM) Ventral Patch (PVP(TM) Device)
Devices Surgery
 HSMN NewsFeed - 10 Dec 2008
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2008
Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2008
ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners
Devices Wound Care
 HSMN NewsFeed - 1 Dec 2008
Johnson & Johnson Announces Definitive Agreement to Acquire Mentor Corporation
Devices Mergers & Acquisitions
 HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
Biopharmaceuticals
 HSMN NewsFeed - 26 Nov 2008
FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections
Biopharmaceuticals
 HSMN NewsFeed - 24 Nov 2008
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Nov 2008
Study Finds Catheter Ablation with the NAVISTAR(R) THERMOCOOL(R) Catheter Superior to Anti-Arrhythmic Drug Therapy for the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 24 Oct 2008
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Oct 2008
Sarnova Names Craig Davenport Chief Executive Officer
Devices Distribution Personnel
 HSMN NewsFeed - 13 Oct 2008
Cordis Announces New Leadership Positions in Key Business Groups
Devices Cardiology Personnel
 HSMN NewsFeed - 1 Oct 2008
Boston Scientific Announces Court Decision
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 15 Sep 2008
Boston Scientific Announces Court Decision
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 12 Sep 2008
Christine A. Poon Plans Retirement from Johnson & Johnson in Early 2009
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 4 Sep 2008
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2008
First Patient Enrolled in Study Evaluating S.M.A.R.T. (R) Nitinol Self-Expandable Stent System in Leg Disease
Devices Interventional
 HSMN NewsFeed - 28 Aug 2008
The CYPHER(R) Sirolimus-eluting Coronary Stent Outperforms the Taxus(R) Stent in People with Diabetes According to Clinical Data in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2008
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Aug 2008
Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, to its Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Aug 2008
Alkermes Announces Approval of VIVITROL(R) for the Treatment of Alcohol Dependence in Russia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Jul 2008
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Rivaroxaban
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jul 2008
Osiris Therapeutics Appoints Chief Financial Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 24 Jul 2008
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 16 Jul 2008
Elemé Medical Announces $18 Million ''Series C'' Financing
Devices Venture Capital
 HSMN NewsFeed - 12 Jul 2008
Amgen and Ortho Biotech Settle Antitrust Suit
Biopharmaceuticals Oncology Litigation
 HSMN NewsFeed - 30 Jun 2008
FDA Approves EVOLENCE(R), a New Generation Collagen-Based Facial Filler
Devices Dermatology FDA
 HSMN NewsFeed - 16 Jun 2008
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 30 May 2008
Rivaroxaban Superior to U.S.-Approved Dosing Regimen for Enoxaparin in Reducing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
Biopharmaceuticals Orthopaedic Surgery
 HSMN NewsFeed - 8 May 2008
Boston Scientific Announces Dismissal of Johnson & Johnson Patent Lawsuit in Canada
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 7 May 2008
Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2008
Cordis Corporation Launches New Peripheral Angioplasty Balloon Catheters
Devices Interventional
 HSMN NewsFeed - 5 May 2008
Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 25 Apr 2008
Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.
Devices Personnel
 HSMN NewsFeed - 21 Apr 2008
VIVUS Appoints Charles J. Casamento to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2008
Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery
Devices Surgery
 HSMN NewsFeed - 7 Apr 2008
Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
Devices Personnel
 HSMN NewsFeed - 31 Mar 2008
IMPAX Establishes Branded Products Division with Appointments of Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2008
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 27 Mar 2008
Discovery Labs Adds Two Executives to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2008
FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Mar 2008
Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2008
Omron Healthcare Names New Chief Operating Officer Bob Kondraske
Devices Personnel
 HSMN NewsFeed - 11 Feb 2008
PolyRemedy Raises $25 Million in Funding to Revolutionize the Delivery of Wound Care Using Robotics and Nano-Technology at the Point of Care
Devices Wound Care Venture Capital
 HSMN NewsFeed - 11 Feb 2008
Spectrum Pharmaceuticals Strengthens Management; Appoints Oncologist Richard A. Bender, MD as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2008
New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 6 Feb 2008
Xanodyne Announces Two Senior Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2008
Softscope Medical Technologies, Inc. Announces the Appointment of John E. Schellhorn as Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 23 Jan 2008
Bausch & Lomb Names Gerald M. Ostrov Chairman and Chief Executive Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 21 Jan 2008
FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
Biopharmaceuticals FDA HIV/AIDS
 HSMN NewsFeed - 21 Jan 2008
AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 15 Jan 2008
Medivation Names Rohan Palekar Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2008
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Children's Zyrtec(R) Chewable Tablets for Allergy Relief and Children's Zyrtec(R) Chewable Tablets for Hives Relief
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Jan 2008
Power Medical Interventions, Inc. to Resume Sales of Circular Stapler Products in Germany
Devices Surgery Litigation
 HSMN NewsFeed - 7 Jan 2008
Alkermes Announces Agreement for the Commercialization of VIVITROL in Russia/CIS
Biopharmaceuticals
 HSMN NewsFeed - 2 Jan 2008
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
Biopharmaceuticals Distribution
 HSMN NewsFeed - 18 Dec 2007
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 18 Dec 2007
Cyberonics Licenses Obesity-Related Patents
Devices Licensing
 HSMN NewsFeed - 12 Dec 2007
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2007
Pivotal Phase III Data Showed Rivaroxaban Was Statistically Superior to Enoxaparin in Preventing Venous Thromboembolism (VTE) in Patients Following Hip Replacement Surgery
 HSMN NewsFeed - 5 Dec 2007
Contact Lens Shift Can Compromise Vision of People with Astigmatism with the Blink of an Eye
Devices Ophthalmology
 HSMN NewsFeed - 5 Dec 2007
Amarin Signs Agreement to Acquire Ester Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2007
FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2007
Argos Therapeutics and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Nov 2007
Johnson & Johnson Announces Changes to Accelerate Growth
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 14 Nov 2007
Lev Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2007
Given Imaging Announces InScope Cooperation Agreement to End
Devices Gastroenterology
 HSMN NewsFeed - 31 Oct 2007
Boston Scientific Announces Verdict in Cordis Litigation
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 29 Oct 2007
Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Oct 2007
Karen Zaderej Named Chief Operating Officer of AxoGen, Incorporated
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 17 Oct 2007
Phenomix Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2007
FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 11 Oct 2007
Given Imaging Announces National Government Services Expands Policy to Cover Capsule Endoscopy of the Esophagus
Devices Gastroenterology Reimbursement
 HSMN NewsFeed - 8 Oct 2007
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2007
Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 2 Oct 2007
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 2 Oct 2007
Oralflo Helps the Medicine Go Down
Devices
 HSMN NewsFeed - 28 Sep 2007
FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
Devices Surgery FDA
 HSMN NewsFeed - 25 Sep 2007
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2007
The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms the Taxus Stent in Small Coronary Vessels According to New Clinical Data Analysis Published in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Sep 2007
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2007
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
Biopharmaceuticals
 HSMN NewsFeed - 17 Sep 2007
Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
Devices Litigation Interventional Cardiology
 HSMN NewsFeed - 13 Sep 2007
Largest Study to Date Finds Drug-Eluting Stents and Bare-Metal Stents Yield Similarly Low Mortality Rates
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2007
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 5 Sep 2007
Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Sep 2007
Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2007
Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Aug 2007
CryoCath Announces Addition to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 21 Aug 2007
Medtronic Announces Alliance with LifeScan to Bring Leading Blood Glucose Meter to Its Diabetes Patients in United States
Devices Endocrinology
 HSMN NewsFeed - 10 Aug 2007
Pacific Beach BioSciences and Dong Wha Pharmaceuticals Sign Exclusive License Agreement to Develop and Commercialize Zabofloxacin (PB-101, DW-224a)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Aug 2007
Carticept Medical Expands Management Team with Appointment of Chris Fair to Vice President, Sales and Marketing
Devices Orthopaedic Personnel
 HSMN NewsFeed - 6 Aug 2007
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2007
Micrus Endovascular Signs Distribution Agreement to Enter Chinese Market
Devices Interventional Neurology Distribution
 HSMN NewsFeed - 31 Jul 2007
Johnson & Johnson Plans to Improve Overall Cost Structure, While Continuing to Invest in Opportunities for Sustained Profitable Growth
Biopharmaceuticals Devices
 HSMN NewsFeed - 8 Jul 2007
Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2007
Lev Pharmaceuticals, Inc. Announces Completion of Marketing and Sales Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2007
FDA Issues Approvable Letter for RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jun 2007
William D. Perez of Wm. Wrigley Jr. Company Appointed to Johnson & Johnson Board of Directors
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 6 Jun 2007
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2007
Swiss Regulatory Authority Grants Accelerated Assessment of Planned Market Authorization Application for Ceftobiprole
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 May 2007
Paladin Acquires Zincofax(R) from Johnson & Johnson, Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 22 May 2007
CYPHER(R) Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2007
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 May 2007
Barnev Inc., Developer of FDA-Cleared Computerized Labor Monitoring System Appoints James F. Puffenberger President, Announces Opening of North American Headquarters
Devices Monitoring Personnel
 HSMN NewsFeed - 7 May 2007
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
Devices Interventional Cardiology
 HSMN NewsFeed - 4 May 2007
Royalty Pharma Acquires a Portion of New York University's Royalty Interest in Remicade(R) for $650 Million
Biopharmaceuticals
 HSMN NewsFeed - 18 Apr 2007
Iroko Pharmaceuticals Appoints John Vavricka as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2007
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
Biopharmaceuticals Devices Cardiology
 HSMN NewsFeed - 16 Apr 2007
Panacos Announces New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2007
Cordis Corporation Starts Pivotal Trial for ExoSeal(TM) Vascular Closure Device
Devices Interventional
 HSMN NewsFeed - 28 Mar 2007
AVI BioPharma Chairman and CEO Resigns
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2007
Cobalis Appoints Three Pharmaceutical Industry Executives to Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2007
Labopharm appoints Vice President Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2007
Johnson & Johnson Statement on Voluntary Disclosure
Devices Personnel
 HSMN NewsFeed - 12 Feb 2007
FONAR Increases in-House Advertising Capability; Hires Creative Director of Leapfrog Communications as Vice President of Advertising
Devices Personnel
 HSMN NewsFeed - 1 Feb 2007
Johnson & Johnson Completes Acquisition of Conor Medsystems, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 31 Jan 2007
Conor Medsystems Stockholders Approve Merger Agreement with Johnson & Johnson
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 31 Jan 2007
Hospitals, Healthcare Providers to Save with Premier Blood Glucose Meters, Reagents, Consumables, Service Agreements
Diagnostics Group Purchasing
 HSMN NewsFeed - 18 Jan 2007
CoreValve Announces the Appointment of Dolf Meewis as Vice President of International Sales
Devices Cardiology Personnel
 HSMN NewsFeed - 17 Jan 2007
Medivation Names Lisa Taylor Vice President of Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2007
Johnson & Johnson Wound Management Worldwide Introduces SURGIFOAM* Absorbable Gelatin Sponge
Devices Wound Care
 HSMN NewsFeed - 9 Jan 2007
Agile Therapeutics Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2006
CellSearch(TM) Circulating Tumor Cell Kit Receives FDA Clearance for Monitoring Patients with Metastatic Breast Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 13 Dec 2006
Ortho-Clinical Diagnostics Receives FDA Approval for First Blood-Screening Test for Chagas' Disease
Diagnostics FDA
 HSMN NewsFeed - 12 Dec 2006
Johnson & Johnson Acquisition of Pfizer Consumer Healthcare Receives Clearance from U.S. Federal Trade Commission (FTC)
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2006
Basilea to Co-Promote Ceftobiprole
Biopharmaceuticals
 HSMN NewsFeed - 16 Nov 2006
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2006
Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER(R) Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Nov 2006
Janssen, L.P. Selects INVEGA(TM) (paliperidone) Extended Release tablets as Brand Name for Its Investigational Atypical Antipsychotic
Biopharmaceuticals
 HSMN NewsFeed - 8 Nov 2006
Use of Hyperthermia Therapy in Treating Primary and Recurrent Breast Cancer Highlights Breast Cancer Congress
Devices Oncology
 HSMN NewsFeed - 3 Nov 2006
Alphatec Announces Court Decision Denying Preliminary Injunction Against Two of Company's Key Pedicle Screws
Devices Orthopaedic Neurosurgery Litigation
 HSMN NewsFeed - 27 Oct 2006
James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development
Diagnostics Personnel
 HSMN NewsFeed - 27 Oct 2006
STAAR Surgical Expands Sales and Regulatory/Quality Assurance Teams
Devices Ophthalmology Personnel
 HSMN NewsFeed - 24 Oct 2006
U.S. District Court Grants Request for Preliminary Injunction to Ortho-McNeil Neurologics, Inc. for TOPAMAX(R)
Biopharmaceuticals Neurology Generics Litigation
 HSMN NewsFeed - 24 Oct 2006
Cordis to Study Impact of Contributing Factors to Stent Thrombosis in Expansion of 30,000-Stent Patient Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2006
Boehringer Ingelheim Pharmaceuticals, Inc. Announces Agreement to Acquire Zantac(R) from Johnson & Johnson and the Pfizer Consumer Healthcare Business
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 12 Oct 2006
David Kandzari, M.D., International Expert in Interventional Cardiology, Named Chief Medical Officer of Cordis Cardiology
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 4 Oct 2006
Data Suggest Different Outcomes Between The CYPHER(R) Sirolimus-Eluting Coronary Stent and the Taxus Stent In 'Real World' Settings and Small Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Oct 2006
IMPAX Announces Dismissal of Lawsuit Related to Generic Concerta(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter for Paliperidone ER for the Treatment of Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Sep 2006
Kurt H. Kruger Joins Cyberkinetics as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 15 Sep 2006
ETHICON Introduces New, Advanced Device for Laparoscopic Hysterectomy
Devices Surgery
 HSMN NewsFeed - 14 Sep 2006
Medivation Appoints Dr. Andrew A. Protter Vice President of Preclinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2006
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Sep 2006
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 7 Sep 2006
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 6 Sep 2006
First Drug-Eluting Stent Approved in Europe for Most Severe Form of Arterial Disease in the Leg
Devices Interventional Regulatory
 HSMN NewsFeed - 6 Sep 2006
Data Suggest the Cypher(R) Sirolimus-Eluting Coronary Stent Provides Sustained Clinical Benefits In Patients With Coronary Artery Disease Compared to Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jul 2006
St. Francis Medical Technologies Appoints David Clapper and Joseph Cutts to its Board of Directors
Devices Personnel
 HSMN NewsFeed - 11 Jul 2006
SurModics' Hydrophilic Coating Used on CYPHER SELECT(TM) PLUS
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jul 2006
MGI PHARMA Announces License Agreement with Cilag GmbH, a Johnson & Johnson Company, for Dacogen(TM) (decitabine) for Injection
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 28 Jun 2006
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for New Balloon Dilation Catheter
Devices Distribution Interventional Cardiology
 HSMN NewsFeed - 26 Jun 2006
Johnson & Johnson to Acquire Pfizer Consumer Healthcare; Combination Creates World's Premier Consumer Health Care Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Jun 2006
In a Phase III Lipid Interim Analysis, ACAPODENE Treatment Lowered Cholesterol and Raised HDL In Prostate Cancer Patients On Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 May 2006
Cordis Corporation to Establish New Innovative Research Center in Silicon Valley
Devices Cardiology
 HSMN NewsFeed - 25 May 2006
Dr. Frank J. Bellizzi Appointed President of Zila's Pharmaceutical Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2006
Clinical Study of Investigational Drug Paliperidone ER Demonstrated Efficacy and Tolerability in the Treatment of Patients With Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 16 May 2006
Study Suggests Drug-Eluting Stent Type and Vessel Size are Important Predictors of Reblockage in Coronary Artery
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2006
Patient Registry to Evaluate Long-Term Safety and Efficacy of Cordis Next Generation Drug-Eluting Coronary Stents in Clinical Practice
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2006
District Court Issues Two Decisions Regarding Patent Litigation Between Cordis Corporation and Boston Scientific
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 May 2006
Boston Scientific Announces Court Upholds Jury Decisions in Patent Case with J&J
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 May 2006
ETHICON Announces CE Mark Approval of New Device to Treat Female Stress Incontinence
Devices Regulatory
 HSMN NewsFeed - 10 May 2006
AxioMed Spine Corporation Announces the Appointment of Patrick McBrayer as President and CEO
Devices Personnel
 HSMN NewsFeed - 9 May 2006
ETHICON, Inc. Completes Acquisition of Vascular Control Systems, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2006
Investigators Report Findings of a Phase 2 Pilot Study Evaluating Postoperative Renal Effects in Heart Failure Patients Treated with Nesiritide
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 May 2006
Janssen-Cilag Submits Marketing Authorization Application in Europe for New Treatment for Schizophrenia
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 May 2006
Raven Appoints George F. Schreiner, M.D., Ph.D., Chief Executive Officer
Biopharmaceuticals Oncology Personnel
Return to NewsFeed  

 Additional items found! 433

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 433 additional stories matching:
Johnson & Johnson,
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!